ENFORTUMAB VEDOTIN-EJFV: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
26.6%
Female
73.4%
Male
Age Information
The average age of patients reporting adverse events with ENFORTUMAB VEDOTIN-EJFV is 71.6 years.
Geographic Distribution
The majority of adverse event reports for ENFORTUMAB VEDOTIN-EJFV originate from JP.
Report Summary & Outcomes
3,733
Total Reports
3,733
As Primary/Secondary Suspect
747
Deaths Reported
1,149
Hospitalizations
135
Life-Threatening
44
Disabilities
Reporting Timeline
First adverse event report: 20190201. Most recent report: 20250911. View full timeline →